Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-312023-04-01false44truetrue 07577634 2023-04-01 2024-03-31 07577634 2022-04-01 2023-03-31 07577634 2024-03-31 07577634 2023-03-31 07577634 c:Director1 2023-04-01 2024-03-31 07577634 c:Director1 2024-03-31 07577634 c:Director2 2023-04-01 2024-03-31 07577634 c:Director2 2024-03-31 07577634 c:Director3 2023-04-01 2024-03-31 07577634 c:Director3 2024-03-31 07577634 c:Director4 2023-04-01 2024-03-31 07577634 c:Director5 2023-04-01 2024-03-31 07577634 c:Director6 2023-04-01 2024-03-31 07577634 c:Director6 2024-03-31 07577634 c:RegisteredOffice 2023-04-01 2024-03-31 07577634 d:CurrentFinancialInstruments 2024-03-31 07577634 d:CurrentFinancialInstruments 2023-03-31 07577634 d:Non-currentFinancialInstruments 2024-03-31 07577634 d:Non-currentFinancialInstruments 2023-03-31 07577634 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 07577634 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 07577634 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 07577634 d:Non-currentFinancialInstruments d:AfterOneYear 2023-03-31 07577634 d:ShareCapital 2024-03-31 07577634 d:ShareCapital 2023-03-31 07577634 d:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 07577634 d:RetainedEarningsAccumulatedLosses 2024-03-31 07577634 d:RetainedEarningsAccumulatedLosses 2023-03-31 07577634 c:OrdinaryShareClass1 2023-04-01 2024-03-31 07577634 c:OrdinaryShareClass1 2024-03-31 07577634 c:OrdinaryShareClass1 2023-03-31 07577634 c:FRS102 2023-04-01 2024-03-31 07577634 c:Audited 2023-04-01 2024-03-31 07577634 c:FullAccounts 2023-04-01 2024-03-31 07577634 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07577634 c:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 07577634 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered number: 07577634










GCP HEALTHCARE 1 LIMITED

AUDITED
FINANCIAL STATEMENTS

FOR THE YEAR ENDED
31 MARCH 2024
 






 



 






 
GCP HEALTHCARE 1 LIMITED
 

COMPANY INFORMATION


Directors
Ms A L Bath (appointed 8 December 2023)
Mr R A J Wright (resigned 8 December 2023)
Mrs S J Johnston (resigned 8 December 2023)
Mr P W Kent 
Mr N S Parker 
Ms C Marlow (appointed 8 December 2023)




Registered number
07577634



Registered office
24 Savile Row

London

United Kingdom

W1S 2ES




Independent auditors
Wellden Turnbull Limited
Chartered Accountants & Statutory Auditors

Albany House

Claremont Lane

Esher

Surrey

KT10 9FQ





 
GCP HEALTHCARE 1 LIMITED
 

CONTENTS



Page
Balance Sheet
 
 
1
Notes to the Accounts
 
 
2 - 7


 
GCP HEALTHCARE 1 LIMITED
REGISTERED NUMBER: 07577634

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£000
£000

  

Current assets
  

Debtors: amounts falling due after more than one year
 5 
15,167
15,531

Debtors: amounts falling due within one year
 5 
216
458

Cash at bank and in hand
 6 
272
-

  
15,655
15,989

Current liabilities
  

Creditors: amounts falling due within one year
 7 
(576)
(574)

Net current assets
  
 
 
15,079
 
 
15,415

Total assets less current liabilities
  
15,079
15,415

Creditors: amounts falling due after more than one year
 8 
(16,264)
(16,539)

  

Net liabilities
  
(1,185)
(1,124)


Capital and reserves
  

Called up share capital 
 9 
-
-

Profit and loss account
 10 
(1,185)
(1,124)

  
(1,185)
(1,124)


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Ms C Marlow
Director

Date: 18 March 2025

Page 1

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

GCP Healthcare 1 Limited is a private company, limited by shares, incorporated in England and Wales, registered number 07577634. The registered office is 24 Savile Row, London, W1S 2ES.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies (see note 3).

These financial statements are presented in sterling which is the functional currency of the Company and rounded to the nearest £'000 unless otherwise stated.

The following principal accounting policies have been applied:

  
2.2

Compliance with accounting standards

The financial statements have been prepared using FRS102 The Financial Reporting Standard applicable in the UK and the Republic of Ireland, including the disclosure and presentation requirements of Section 1A, applicable to small companies. There were no material departures from that standard.

  
2.3

Going concern

The Company was loss making in the period and is in a net liability position at the year end date. The financial statements have been prepared on a going concern basis which means that the Company can be expected to meet its liabilities as they fall due for a period of 12 months from the date of signing these financial statements. In assessing the appropriateness of the going concern basis of preparation the Directors have taken into account the key risks of the business as well as the Company’s business model and the availability of cash resources.
The Company is part of a financing structure, the underlying loans structured to ensure that actual cash inflows from the loan debtor exceed the Company's cash outflows to service the loan creditor and overheads over the loan term. The Directors have prepared financial models over the life of the loan which support this position. Further, the Directors cite the ongoing support of fellow group companies including the Company’s lender to not call its debt to the detriment of the Company. On this basis the Directors consider it is appropriate to prepare the financial statements on a going concern basis.

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. 
Turnover comprises interest receivable from the provision of loan financing. Interest receivable is recognised over the loan period using the effective interest method, which takes into account related fees and transaction costs.

Page 2

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

  
2.5

Interest payable

Interest payable is recognised using the effective interest method, which takes into account related fees and transaction costs. Interest payable is included within cost of sales as it is directly attributable to the interest receivable included in revenue.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.





 

Page 3

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)


2.9
Financial instruments (continued)

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Page 4

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2024

3.


Judgements in applying accounting policies and key sources of estimation uncertainty

In preparing the financial statements, management is required to make judgements, estimates and assumptions which affect reported income, expenses, assets, liabilities and disclosure of contingent assets and liabilities. Use of available information and application of judgement are inherent in the formation of estimates, together with past experience and expectations of future events that are believed to be reasonable under the circumstances. Actual results in the future could differ from such estimates.
Management do not consider the Company to have any key sources of estimation uncertainty nor any significant judgements or assumptions in preparing these financial statements.


4.


Employees

The Company has no employees other than the Directors, who did not receive any remuneration (2023 -
£NIL).



5.


Debtors

2024
2023
£000
£000

Due after more than one year

Other debtors
15,167
15,531


2024
2023
£000
£000

Due within one year

Other debtors
216
457


Other debtors comprise loan receivable balances accounted for at amortised cost.


6.


Cash and cash equivalents

2024
2023
£000
£000

Cash at bank and in hand
272
-


Page 5

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£000
£000

External loan
482
480

Other creditors
86
86

Accruals and deferred income
8
8

576
574


Refer to note 8 for details on external loans.


8.


Creditors: Amounts falling due after more than one year

2024
2023
£000
£000

External loan
16,264
16,539


External loans comprise interest bearing loan notes which are accounted for at amortised cost and are repayable by instalments
The loan notes are secured by a debenture over all assets of the Company, present and future.

The aggregate amount of liabilities repayable wholly or in part more than five years after the balance sheet date is:

2024
2023
£000
£000


Repayable by instalments
14,411
14,608

Repayable other than by instalments
1,425
1,360

15,836
15,968



9.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



1,000 (2023 - 1,000) Ordinary shares of £0.01 each
10
10



10.


Reserves

Profit and loss account

The profit and loss account represents cumulative profits and losses net of all adjustments.

Page 6

 
GCP HEALTHCARE 1 LIMITED
 

 
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2024

11.


Related party transactions

The Company is exempt under the terms of Financial Reporting Standard 102 (FRS 102) paragraph 33.1A, from disclosing related party transactions with other group companies, on the grounds that the Company is wholly owned within the Group.


12.


Controlling party

The Company's immediate and ultimate parent undertaking is GCP Intermediary Holdings Limited, a company incorporated in England and Wales.
The smallest and largest group of undertakings into which the results of the Company are consolidated is headed byGCP Intermediary Holdings Limited .
The registered office address of GCP Intermediary Holdings Limited is 24 Savile Row, London, W1S 2ES. The consolidated financial statements are available from the registered office address Companies House.


13.


Auditors' information

The auditors' report on the financial statements for the year ended 31 March 2024 was unqualified.

The audit report was signed on 18 March 2025 by Mark Nelligan FCA (Senior Statutory Auditor) on behalf of Wellden Turnbull Limited.


Page 7